Showing Results for
- Academic Journals (34)
Search Results
- 34
Academic Journals
- 34
- Search Terms:
- 1From: Trials. (Vol. 8) Peer-ReviewedAuthors: Mike Clarke (corresponding author) [1] Introduction Fifteen years ago, what was to become OMERACT met for the first time in The Netherlands to discuss ways in which the multitude of outcomes in assessments...
- 2From: Trials. (Vol. 8) Peer-ReviewedAuthors: Helen Atherton (corresponding author) [1]; Debbie Banks [1]; Ruth Harbit [1]; Linzie Long [1]; Fiona Chadd [1]; Phillip Hay [2]; Sally Kerry [1]; Ian Simms [3]; Pippa Oakeshott [1] Background The Prevention...
- 3From: Trials. (Vol. 8) Peer-ReviewedAuthors: Jeremy Dale (corresponding author) [1]; Isabela Caramlau [1]; Andrea Docherty [2]; Jackie Sturt [1]; Hilary Hearnshaw [1] Background Numerous studies have reported the relationship between self-management...
- 4From: Trials. (Vol. 8) Peer-ReviewedAuthors: Rachel M Cooney [1]; Bryan F Warren [1]; Douglas G Altman [2]; Maria T Abreu [3]; Simon PL Travis (corresponding author) [1] Background Clinical trials determining the efficacy of new treatments need...
- 5From: Trials. (Vol. 8) Peer-ReviewedAuthors: Paula R Williamson (corresponding author) [1]; Catrin Tudur Smith [1]; Josemir W Sander [2]; Anthony G Marson [3] Background Patients with a new diagnosis of epilepsy are usually prescribed an antiepileptic...
- 6From: Trials. (Vol. 8) Peer-ReviewedAuthors: Jayne F Tierney (corresponding author) [1]; Lesley A Stewart [2]; Davina Ghersi [3]; Sarah Burdett [1]; Matthew R Sydes [4] Background Time-to-event outcomes take account of whether an event takes place and...
- 7From: Trials. (Vol. 8) Peer-ReviewedAuthors: Britta A Jung (corresponding author) (equal contributor) [1]; Heinrich Wehrbein [1]; Werner Hopfenmüller [2]; Winfried Harzer [3]; Tomasz Gedrange [4]; Peter Diedrich [5]; Martin Kunkel (equal contributor) [6]...
- 8From: Trials. (Vol. 8) Peer-ReviewedAuthors: Michèle Hamon [1]; Francesco Burzotta [2]; Catherine Oppenheim [3]; Rémy Morello [4]; Fausto Viader [5]; Martial Hamon (corresponding author) [6]; [7] Background Acute cerebral infarction following cardiac...
- 9From: Trials. (Vol. 8) Peer-ReviewedAuthors: Peter Tugwell (corresponding author) [1]; Maarten Boers [2]; Peter Brooks [3]; Lee Simon [4]; Vibeke Strand [5]; Leanne Idzerda [6] What is OMERACT? "Clinical trials are only as credible as their endpoints"...
- 10From: Trials. (Vol. 8) Peer-ReviewedAuthors: Nicky HGM Peters (corresponding author) [1]; Inne HM Borel Rinkes [2]; Willem PTM Mali [1]; Maurice AAJ van den Bosch [1]; Remmert K Storm [3]; Peter W Plaisier [4]; Erwin de Boer [5]; Adriaan J van Overbeeke...
- 11From: Trials. (Vol. 8) Peer-ReviewedAuthors: Merrick F Zwarenstein (corresponding author) [1,2]; Katie N Dainty [3]; Sherman Quan [3]; Alex Kiss [4]; Neill KJ Adhikari [5,6] Background & rationale A medication error, as defined by the National...
- 12From: Trials. (Vol. 8) Peer-ReviewedAbstract Background: In the United Kingdom (UK), there is an extensive market for the class 'A' drug heroin. Many heroin users spend time in prison. People addicted to heroin often require prescribed medication when...
- 13From: Trials. (Vol. 8) Peer-ReviewedAuthors: Arash Nickkholgh [1]; Heinz Schneider [2]; Jens Encke [3]; Markus W Büchler [1]; Jan Schmidt [1]; Peter Schemmer (corresponding author) [1] Background Immunonutrition Patients with end-stage liver disease...
- 14From: Trials. (Vol. 8) Peer-ReviewedAuthors: Katja Schlosser (corresponding author) [1]; Johannes A Veit [2]; Stefan Witte [2,3]; Emilio DomÃnguez Fernández [1]; Norbert Victor [3]; Hans-Peter Knaebel [2]; Christoph M Seiler [2]; Matthias Rothmund [1]...
- 15From: Trials. (Vol. 8) Peer-ReviewedAuthors: Ludovic Reveiz (corresponding author) [1,4]; Karmela Krle?a-Jeri? [2]; An-Wen Chan [3]; Sylvia De Aguiar [4] Background Over the past few years, several key initiatives have enabled substantial progress in...
- 16From: Trials. (Vol. 8) Peer-ReviewedAuthors: Merrick Zwarenstein (corresponding author) [1,2,3]; Scott Reeves [1,4,5]; Ann Russell [1]; Chris Kenaszchuk [1]; Lesley Gotlib Conn [6]; Karen-Lee Miller [1]; Lorelei Lingard [5,7]; Kevin E Thorpe [1,8]...
- 17From: Trials. (Vol. 8) Peer-ReviewedAuthors: Andrew J Vickers (corresponding author) [1]; Michael W Kattan [2]; Sargent Daniel [3] Introduction The typical approach to interpreting and applying the results of a randomized trial to clinical practice is...
- 18From: Trials. (Vol. 8) Peer-ReviewedAuthors: Sandra Y Silva [1]; Ligia C Rueda [1]; Gustavo A Márquez [1]; Marcos López [2]; Daniel J Smith [2]; Carlos A Calderón [3]; Juan C Castillo [1]; Jaime Matute [4]; Christian F Rueda-Clausen [1]; Arturo Orduz...
- 19From: Trials. (Vol. 8) Peer-ReviewedAuthors: CAH Klazen (corresponding author) [1,11]; HJJ Verhaar [2]; LEH Lampmann [1]; JR Juttmann [3]; MC Blonk [4]; FH Jansen [5]; AV Tielbeek [5]; MC Schoemaker [1]; E Buskens [6]; Y van der Graaf [6]; X Janssens [7];...
- 20From: Trials. (Vol. 8) Peer-ReviewedAuthors: Catrin Tudur Smith (corresponding author) [1]; Anthony G Marson [2]; David W Chadwick [2]; Paula R Williamson1 [1] Background Epilepsy is a common neurological condition with a prevalence of around 0.5% and...